Ceruloplasmin is a multicopper oxidase essential for normal iron homeostasis. 
Introduction
Copper is an essential trace element that plays a critical role in the biochemistry of all aerobic organisms (1) . This metal permits the facile transfer of electrons by specific cuproenzymes in critical metabolic pathways. The chemical reactivity of copper also accounts for the toxicity of this metal when cellular homeostasis is impaired and therefore specific mechanisms have evolved which regulate copper trafficking and compartmentalization within the cell. Under physiological circumstances intracellular copper availability is extraordinarily restricted and as a result the delivery of copper to specific pathways and target proteins is determined by metallochaperones which protect this metal from intracellular scavenging (2, 3) . Biochemical and structural analysis of these copper chaperones indicates that copper transfer to specific targets within the cytoplasm is mediated by an intricate series of events involving direct protein-protein interaction (4) . The majority of known cuproenzymes are synthesized within the secretory pathway and copper gains access to this compartment via the trans-Golgi resident copper transporting ATPases present in all cells (1) . Despite the essential role of these cuproenzymes, there is currently little or no understanding of the mechanisms of copper incorporation into these proteins within the secretory pathway.
Ceruloplasmin is a copper-containing plasma ferroxidase that plays an essential role in mammalian iron homeostasis (5) . This protein is a member of the multicopper oxidase family of enzymes, utilizing the electron chemistry of bound copper ions to couple iron oxidation with the four electron reduction of dioxygen. Inherited loss of function of ceruloplasmin in humans results in a progressive neurodegenerative disease due to excessive iron accumulation within the basal ganglia (6, 7) . Ceruloplasmin is synthesized in hepatocytes and secreted into the plasma following the incorporation of six atoms of copper in the secretory pathway (8, 9) . Copper does by guest on November 17, 2017 http://www.jbc.org/ Downloaded from not affect the rate of ceruloplasmin synthesis or secretion; however, failure to incorporate this metal during synthesis results in secretion of an unstable apoprotein that is devoid of oxidase activity and rapidly degraded in the plasma (10, 11) . In Wilson disease the absence or impaired function of a copper-transporting ATPase disrupts copper movement into the secretory pathway resulting in the decreased serum ceruloplasmin observed in affected patients (1) .
Ceruloplasmin is characterized by the presence of three types of spectroscopically distinct copper sites. Three type I copper sites result in strong absorption at 600 nm conferring an intense blue color to this protein. A single type II copper is coordinated by four imidazole nitrogens and is in close proximity to two antiferromagnetically coupled type III copper ions which absorb at 330 nm. The type II and type III coppers have been shown to form a trinuclear copper cluster which is the site of oxygen binding during the catalytic cycle (12) . Resolution of the structure of human ceruloplasmin by X-ray crystallography has confirmed the presence of this trinuclear cluster as well as the identity of each of the amino acid copper ligands (13) . In the current study, this molecular information, taken together with a well-defined expression system that reflects the physiological mechanisms of ceruloplasmin synthesis and secretion, provided the opportunity to directly examine the mechanisms of copper incorporation into this protein within the secretory pathway.
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Experimental Procedures
Cell Culture and Metabolic Labeling. HepG2 and Chinese hamster ovary (CHO) cells were obtained from the American Type Culture Collection and maintained in media with 10% fetal bovine serum as previously described (14) . CHO cells were transfected with Lipofectamine (Invitrogen) according to the manufacturer's instructions and forty-eight hours later incubated for 20 minutes with [
35 S]methionine and [ 35 S]cysteine, chased for the indicated times in serumfree media, followed by collection of lysate and media for immunoprecipitation and 7.5% SDSpolyacrylamide gel electrophoresis (PAGE ) (14) . For copper labeling, CHO cells were incubated for the indicated times with 300 µCi/ml 64 Cu, chased with serum-free media containing 100-fold excess copper and media was collected, concentrated using Centricon-30 filters (Millipore) and subjected to SDS-PAGE on 4-20% Tris-HCl gradient gels under nonreducing conditions as described previously (8) . Following quantitative analysis of 64 Cu by PhosphorImager (Molecular Dynamics), proteins were transferred to nitrocellulose membranes, cross linked by ultraviolet radiation and denatured in 25 mM Tris, pH 8, 2% SDS. Immunoblot analysis was performed using an anti-ceruloplasmin antisera as previously described (14) . In some experiments, cells were pretreated for 48 hours with 50 µM of the copper chelator tetraethylenepentamine (TEPA), followed by extensive washing in phosphate-buffered saline (PBS) prior to the addition of 64 Cu. Treatment of cells with this concentration of TEPA reduces the intracellular copper content by 50% without any effect on cell viability (15) . 64 Cu (750 Ci/mmol) was prepared by fast neutron bombardment of a natural zinc target as described previously (16) . Molecular modeling of the G637R mutation was accomplished using the software program InSight (Accelrys) and the published x-ray crystallographic structure of human ceruloplasmin (13) . Autoradiographs were quantitated using UnScanIt imaging software (Silk Scientific) and data fitted to the curve using Sigma Plot (SPSS Science). For experiments with Fet3, wild-type or mutant proteins containing a FLAG epitope were isolated and purified as described previously (19) . 5 µg of these purified proteins were resuspended in either PBS or 50 mM sodium acetate pH 5.6, 1mM sodium ascorbate followed by addition of 500 µCi/ml 64 Cu. Samples were incubated for 1 hr at 20ºC followed by concentration with Centricon-30 filters, SDS-PAGE and analysis for copper incorporation as indicated above and described previously for Fet3 (20) . The electrophoretic analysis suggested the possibility of unique conformational differences between the apo and holo forms of ceruloplasmin. This concept was examined further by subjecting purified human ceruloplasmin to denaturation in increasing concentrations of urea, followed by non-reducing SDS-PAGE and detection with Coomassie blue staining. As can be seen in The further examine the conformational changes that result following copper incorporation into apoceruloplasmin, missense mutations were generated by site-directed mutagenesis at each of the six integral copper-binding sites in ceruloplasmin. To abrogate copper incorporation at each of these sites, histidine to glutamine substitutions were made at each type I Cu-binding site (H276Q, H637Q, and H1026Q), the type II Cu-binding site (H101Q), and each type III Cubinding site (H103Q and H163Q) ( Table I) . To ensure that the results were not due to the replacement of histidine residues, a type I Cu-binding site mutant in which cysteine was converted to serine (C680S) was also generated. Pulse-chase analysis following transfection of each mutant into CHO cells demonstrated kinetics of synthesis and secretion identical to that of wild-type ceruloplasmin, indicating that none of these copper-binding site mutations results in grossly impaired protein folding or trafficking (Fig. 2) . Despite this finding, metabolic labeling with 64 Cu revealed the striking observation that each mutation results in a complete abrogation of copper incorporation into ceruloplasmin (Fig. 3A) . The inability of these copper-binding site mutants to form holoceruloplasmin was verified by immunoblot analysis of the media which revealed the presence only of apoceruloplasmin (Fig. 3B) . In contrast to findings with wild-type ceruloplasmin (Fig. 1A) , incubation of cells transfected with mutant ceruloplasmin in media containing excess CuCl 2 did not result in any detectable holoceruloplasmin (data not shown).
These findings were not the result of the electrophoretic methodology used to detect apo and holoceruloplasmin, as size exclusion chromatography of the media of transfected cells following 64 Cu labeling also revealed copper incorporation only in the wild-type protein (Fig. 4A ).
Interestingly, under these conditions, apo and holoceruloplasmin separate in identical fractions supporting the concept that the size differences observed in SDS-PAGE reflect conformational differences accentuated with this technique (Fig. 4B ). Failure to detect 64 Cu holoceruloplasmin with this method was not due to loss of the transfected proteins as immunoblot analysis of chromatographic fractions revealed abundant apoceruloplasmin in the media from cells transfected with the copper-binding site mutants (Fig. 4B ).
The observation that interference with copper incorporation at any one of the six copperbinding sites abrogates copper incorporation into apoceruloplasmin without disrupting apoceruloplasmin synthesis or secretion suggests a precise mechanism of holoceruloplasmin biosynthesis in the secretory pathway. To directly examine the physiological relevance of these findings, a similar analysis was undertaken using a missense mutation in the ceruloplasmin gene from a patient with aceruloplasminemia. The proband in this family had undetectable levels of circulating serum ceruloplasmin and was found to be homozygous for the mutation G631R (data not shown). As observed previously for the copper-binding site mutants, pulse-chase analysis of the G631R mutation revealed that this protein is synthesized and secreted with kinetics identical to that of wild-type ceruloplasmin (Fig. 5A) . Nevertheless, both 64 Cu metabolic labeling and immunoblot analysis reveals that the G631R mutant is synthesized and secreted only as the apoprotein (Fig. 5B,C ). As noted with the copper-binding mutants, size exclusion chromatography of media following 64 Cu metabolic labeling also failed to reveal any copper incorporation into the G631R mutant ceruloplasmin (data not shown). Molecular modeling of the targeted G631 residue reveals that it is in close proximity to and interacts with H637, one of the (Fig. 7A ). These in vitro findings suggest that the conformation of apoceruloplasmin is the critical determinant for copper incorporation and that each copper binding site plays a key role in this process. The copper concentrations indicated in Fig. 7A reflect the amount added to the media. To precisely quantitate the copper-dependent conversion to holoceruloplasmin under these conditions, experiments were performed in media where the total amount of copper was determined by atomic absorption spectrophotometry. This quantitative analysis of copper incorporation into apoceruloplasmin in vitro revealed a sigmoidal curve, diagnostic of cooperative binding (Fig. 7B) confirming the previous spectroscopic findings (Fig. 8A ). Identical findings were observed when these proteins were copper-labeled utilizing the same tissue culture media as employed for the ceruloplasmin studies (data not shown). The ability to detect partially labeled Fet3 (type I or type II mutants) also suggests that the failure to detect copper-labeled ceruloplasmin under these same conditions is not the result of loss of copper during the electrophoresis. As observed previously in yeast, analysis of copper incorporation into Fet3 under these conditions results in a detectable signal between 75 and 100 kDa due to the glycosylation of this protein (20) . Detection of copper incorporation into mutant Fet3 indicates that our inability to observe copper incorporation into mutant ceruloplasmin (Fig. 3A , 5B) is not the result of the methodological approach utilized and likely reflects unique differences between these two proteins. In support of this concept, while recent studies reveal that chloride is a critical allosteric effector for copper loading into Fet3 (18), copper incorporation into ceruloplasmin was found to be equivalent using either CuCl 2 , Cu(CH 3 COO) 2 , or CuSO 4 as the copper source (Fig. 8B) . 
Discussion
These data, together with previous biochemical studies (8, 14) , indicate that ceruloplasmin is an allosteric protein which enters the late secretory pathway in a copper-competent conformation, where copper serves as a homotropic modulator facilitating the transition to a functional holoprotein. This concept is supported by physical and spectroscopic studies of ceruloplasmin indicating that copper removal results in an apoprotein with altered sedimentation velocity and electrophoretic mobility but retained secondary structure, albeit with weaker tertiary interactions than observed in the holoprotein (21, 22) . We propose that this folding intermediate may be similar to that described for proteins such as apomyoglobin and staphylococcal nuclease A where secondary structure is preserved but flexibility permits the interval motions required for cofactor insertion (23, 24) . In the case of ceruloplasmin this copper-competent state would allow for folding and exit from the endoplasmic reticulum and serve to protect the protein from unfolding in the acidic milieu of the late secretory pathway while still permitting the critical small scale fluctuations required to accommodate copper incorporation.
Biochemical analysis of the G631R patient mutation underscores the essential nature of this copper competent state in the formation of an active, functional ferroxidase (Fig. 5) . In transfected cells this mutation did not affect the critical stages of protein folding required for exit of ceruloplasmin from the endoplasmic reticulum or secretion from the cell but clearly altered the intrinsic protein structure in such a way as to abrogate copper incorporation as revealed with in vitro copper incorporation studies (Fig. 7) . Although greater than 90% of serum ceruloplasmin is in the form of the holoprotein, the marked differences in the serum half-lives of apo and holoceruloplasmin predicts an equivalent rate of hepatic synthesis under steady state conditions by guest on November 17, 2017 http://www.jbc.org/ Downloaded from (25) . This is precisely what is observed in CHO cells transfected with wild-type ceruloplasmin (Fig. 1A) , confirming the validity of this approach for analysis of the G631R mutation.
One of the most critical features of the data in this current study is the observation that copper incorporation into ceruloplasmin requires competency of all six ligand binding sites with no apparent hierarchy for incorporation at any one site. Obviously, at some point during this process, intermediates must form and it remains possible that these represent copper binding to low affinity sites such that only the final step of copper incorporation into a high affinity site is required to bring the protein into the trypsin resistant, stable holo conformation. Under such circumstances the binding at these low affinity sites may still occur in an ordered or hierarchical fashion. While we are currently evaluating the possibility of such a model with fluorescence spectroscopic studies of copper binding to recombinant, purified apoprotein, the existence of such low affinity intermediates seems unlikely given the inability to detect these forms even when excess copper is added to the cell cultures and electrophoresis conditions (data not shown) or in the in vitro copper loading experiments (Fig. 7) .
In contrast to our findings with ceruloplasmin, partial copper intermediates have been observed for the multicopper oxidases Fet3 and bilirubin oxidase (19, 26) and in the case of Fet3 these were readily detected with the methods used in this current study (Fig. 8) . Ceruloplasmin is unique amongst these three multicopper oxidases in containing three type I copper centers and it is possible that this may result in structural or biochemical differences that account for the all-ornone process of copper incorporation. Consistent with this possibility, it has been proposed that the type I copper in domain II of ceruloplasmin may serve in a structural role and not be involved in electron transfer as the high reduction potential at this site prevents oxidation at physiologic pH (27) . As the data in this current study clearly indicate an essential role for this type I copper by guest on November 17, 2017
http://www.jbc.org/ Downloaded from site in holoprotein formation (Fig. 3 H276Q) this does raise the intriguing possibility that this copper, as Cu
1+
, may serve a structural role in protein folding. Regardless of such a possibility, further work will be needed to elucidate the structural mechanisms of the copper incorporation process observed in this current study. Although the precise role of copper in protein folding is not well understood, further study of these mechanisms in ceruloplasmin may have a more broad relevance given recent observations that copper binding to the cellular prion protein induces thermodynamic changes favoring pathologic β-sheet formation (28).
Ceruloplasmin is a single subunit protein with multiple binding sites for copper (Table I) .
This suggested to us the hypothesis that the allosteric effects of copper binding observed in 
